BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 16198105)

  • 1. A and B utrophin in human muscle and sarcolemmal A-utrophin associated with tumours.
    Sewry CA; Nowak KJ; Ehmsen JT; Davies KE
    Neuromuscul Disord; 2005 Nov; 15(11):779-85. PubMed ID: 16198105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The abnormal expression of utrophin in Duchenne and Becker muscular dystrophy is age related.
    Taylor J; Muntoni F; Dubowitz V; Sewry CA
    Neuropathol Appl Neurobiol; 1997 Oct; 23(5):399-405. PubMed ID: 9364465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dystrophin-related protein, utrophin, in normal and dystrophic human fetal skeletal muscle.
    Clerk A; Morris GE; Dubowitz V; Davies KE; Sewry CA
    Histochem J; 1993 Aug; 25(8):554-61. PubMed ID: 8407365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of Utrophin Levels with the Dystrophin Protein Complex and Muscle Fibre Regeneration in Duchenne and Becker Muscular Dystrophy Muscle Biopsies.
    Janghra N; Morgan JE; Sewry CA; Wilson FX; Davies KE; Muntoni F; Tinsley J
    PLoS One; 2016; 11(3):e0150818. PubMed ID: 26974331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of calcineurin signaling attenuates the dystrophic pathology in mdx mice.
    Chakkalakal JV; Harrison MA; Carbonetto S; Chin E; Michel RN; Jasmin BJ
    Hum Mol Genet; 2004 Feb; 13(4):379-88. PubMed ID: 14681302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of neuronal nitric oxide synthase (nNOS) as a pathological marker for the diagnosis of Becker muscular dystrophy with rod domain deletions.
    Torelli S; Brown SC; Jimenez-Mallebrera C; Feng L; Muntoni F; Sewry CA
    Neuropathol Appl Neurobiol; 2004 Oct; 30(5):540-5. PubMed ID: 15488030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downstream utrophin enhancer is required for expression of utrophin in skeletal muscle.
    Tanihata J; Suzuki N; Miyagoe-Suzuki Y; Imaizumi K; Takeda S
    J Gene Med; 2008 Jun; 10(6):702-13. PubMed ID: 18338831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dystrophin-related protein, utrophin, is expressed on the sarcolemma of regenerating human skeletal muscle fibres in dystrophies and inflammatory myopathies.
    Helliwell TR; Man NT; Morris GE; Davies KE
    Neuromuscul Disord; 1992; 2(3):177-84. PubMed ID: 1483043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation and functional significance of utrophin expression at the mammalian neuromuscular synapse.
    Gramolini AO; Wu J; Jasmin BJ
    Microsc Res Tech; 2000 Apr; 49(1):90-100. PubMed ID: 10757882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utrophin upregulation for treating Duchenne or Becker muscular dystrophy: how close are we?
    Miura P; Jasmin BJ
    Trends Mol Med; 2006 Mar; 12(3):122-9. PubMed ID: 16443393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naturally occurring utrophin correlates with disease severity in Duchenne muscular dystrophy.
    Kleopa KA; Drousiotou A; Mavrikiou E; Ormiston A; Kyriakides T
    Hum Mol Genet; 2006 May; 15(10):1623-8. PubMed ID: 16595608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Embryonic myosin is a regeneration marker to monitor utrophin-based therapies for DMD.
    Guiraud S; Edwards B; Squire SE; Moir L; Berg A; Babbs A; Ramadan N; Wood MJ; Davies KE
    Hum Mol Genet; 2019 Jan; 28(2):307-319. PubMed ID: 30304405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The utrophin promoter A drives high expression of the transgenic LacZ gene in liver, testis, colon, submandibular gland, and small intestine.
    Takahashi J; Itoh Y; Fujimori K; Imamura M; Wakayama Y; Miyagoe-Suzuki Y; Takeda S
    J Gene Med; 2005 Feb; 7(2):237-48. PubMed ID: 15538725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of FHL1 as a therapeutic target for Duchenne muscular dystrophy.
    D'Arcy CE; Feeney SJ; McLean CA; Gehrig SM; Lynch GS; Smith JE; Cowling BS; Mitchell CA; McGrath MJ
    Hum Mol Genet; 2014 Feb; 23(3):618-36. PubMed ID: 24087791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissecting the signaling and mechanical functions of the dystrophin-glycoprotein complex.
    Judge LM; Haraguchiln M; Chamberlain JS
    J Cell Sci; 2006 Apr; 119(Pt 8):1537-46. PubMed ID: 16569668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restoration of all dystrophin protein interactions by functional domains in trans does not rescue dystrophy.
    Gardner KL; Kearney JA; Edwards JD; Rafael-Fortney JA
    Gene Ther; 2006 May; 13(9):744-51. PubMed ID: 16307000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dystrophin and utrophin expression in muscle tissues of DMD mouse model after transplantation treatment by bone marrow mesenchymal stem cells].
    Li Z; Zhang C; Xie YM; Chen GJ; Liu XR
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Jun; 26(3):294-7. PubMed ID: 15266833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic strategies for Duchenne and Becker dystrophies.
    Voisin V; de la Porte S
    Int Rev Cytol; 2004; 240():1-30. PubMed ID: 15548414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Association between dystrophin and neuronal nitric oxide synthase in muscles of progressive muscular dystrophy].
    Wang S; Shen D
    Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(3):155-7. PubMed ID: 11953148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of dystrophin and utrophin staining in childhood muscular dystrophy.
    Sundaram C; Vydehi B; Meena K; Murthy J
    Indian J Pathol Microbiol; 2004 Jul; 47(3):367-9. PubMed ID: 16295426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.